Citations (10)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Yudibeth Sixto-López, José Antonio Gómez-Vidal, Nuria de Pedro, Martiniano Bello, Martha Cecilia Rosales-Hernández & José Correa-Basurto. (2022) In silico design of HDAC6 inhibitors with neuroprotective effects. Journal of Biomolecular Structure and Dynamics 40:24, pages 14204-14222.
Read now
Read now
Mona M. Abdel-Atty, Nahla A. Farag, Rabah A. T. Serya, Khaled A. M. Abouzid & Samar Mowafy. (2021) Molecular design, synthesis and in vitro biological evaluation of thienopyrimidine–hydroxamic acids as chimeric kinase HDAC inhibitors: a challenging approach to combat cancer. Journal of Enzyme Inhibition and Medicinal Chemistry 36:1, pages 1290-1311.
Read now
Read now
Yoojin Song, Sun You Park, Zhexue Wu, Kwang-Hyeon Liu & Young Ho Seo. (2020) Hybrid inhibitors of DNA and HDACs remarkably enhance cytotoxicity in leukaemia cells. Journal of Enzyme Inhibition and Medicinal Chemistry 35:1, pages 1069-1079.
Read now
Read now
Articles from other publishers (7)
Phuong Hong Nguyen, Bui Thi Buu Hue, Minh Quan Pham, Tran Phuong Hoa, Quang De Tran, Hosun Jung, Le Trong Hieu, Nguyen Cuong Quoc, Hong Vinh Quang, Nguyen Phu Quy, Hye Jin Yoo & Su-Geun Yang. (2023) Novel histone deacetylase 6 inhibitors using benzimidazole as caps for cancer treatment. New Journal of Chemistry 47:16, pages 7622-7631.
Crossref
Crossref
Nihal AbdElmoniem, Marwa H. Abdallah, Rua M. Mukhtar, Fatima Moutasim, Ahmed Rafie Ahmed, Alaa Edris, Walaa Ibraheem, Alaa A. Makki, Eman M. Elshamly, Rashid Elhag, Wadah Osman, Ramzi A. Mothana & Abdulrahim A. Alzain. (2023) Identification of Novel Natural Dual HDAC and Hsp90 Inhibitors for Metastatic TNBC Using e-Pharmacophore Modeling, Molecular Docking, and Molecular Dynamics Studies. Molecules 28:4, pages 1771.
Crossref
Crossref
Pasquale Linciano, Rosaria Benedetti, Luca Pinzi, Fabiana Russo, Ugo Chianese, Claudia Sorbi, Lucia Altucci, Giulio Rastelli, Livio Brasili & Silvia Franchini. (2021) Investigation of the effect of different linker chemotypes on the inhibition of histone deacetylases (HDACs). Bioorganic Chemistry 106, pages 104462.
Crossref
Crossref
Mona Dawood, Edmond Fleischer, Anette Klinger, Gerhard Bringmann, Letian Shan & Thomas Efferth. (2020) Inhibition of cell migration and induction of apoptosis by a novel class II histone deacetylase inhibitor, MCC2344. Pharmacological Research 160, pages 105076.
Crossref
Crossref
Mona Dawood, Mohamed-Elamir F. Hegazy, Mohamed Elbadawi, Edmond Fleischer, Anette Klinger, Gerhard Bringmann, Claudia Kuntner, Letian Shan & Thomas Efferth. (2020) Vitamin K3 chloro derivative (VKT-2) inhibits HDAC6, activates autophagy and apoptosis, and inhibits aggresome formation in hepatocellular carcinoma cells. Biochemical Pharmacology 180, pages 114176.
Crossref
Crossref
Mona Dawood, Mohamed Elbadawi, Madeleine Böckers, Gerhard Bringmann & Thomas Efferth. (2020) Molecular docking-based virtual drug screening revealing an oxofluorenyl benzamide and a bromonaphthalene sulfonamido hydroxybenzoic acid as HDAC6 inhibitors with cytotoxicity against leukemia cells. Biomedicine & Pharmacotherapy 129, pages 110454.
Crossref
Crossref
Barbara Vergani, Giovanni Sandrone, Mattia Marchini, Chiara Ripamonti, Edoardo Cellupica, Elisabetta Galbiati, Gianluca Caprini, Gianfranco Pavich, Giulia Porro, Ilaria Rocchio, Maria Lattanzio, Marcello Pezzuto, Malgorzata Skorupska, Paola Cordella, Paolo Pagani, Pietro Pozzi, Roberta Pomarico, Daniela Modena, Flavio Leoni, Raffaella Perego, Gianluca Fossati, Christian Steinkühler & Andrea Stevenazzi. (2019) Novel Benzohydroxamate-Based Potent and Selective Histone Deacetylase 6 (HDAC6) Inhibitors Bearing a Pentaheterocyclic Scaffold: Design, Synthesis, and Biological Evaluation. Journal of Medicinal Chemistry 62:23, pages 10711-10739.
Crossref
Crossref